Board Meeting Intimation for Consider And Approve Audited Financial Results (Standalone) For The Quarter And Year Ended March 31 2026.
19-May-2026 | Source : BSECiturgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve audited Financial Results (Standalone) for the quarter and year ended March 31 2026.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
21-Apr-2026 | Source : BSECompliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended on 31.03.2026
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
06-Apr-2026 | Source : BSEIntimation under Regulation 39(3) of SEBI (LODR) Regulations 2015
Corporate Actions
30 May 2026
No Dividend history available
Citurgia Biochemicals Ltd has announced 2:10 stock split, ex-date: 26 Apr 18
No Bonus history available
No Rights history available






